Working Group Members

The Working Group was selected by the Steering Committee. To select Working Group members, the Steering Committee first finalised the scope of the Guidelines and the Guideline chapters. The Steering Committee then nominated the Australian leaders in each field. Like the Steering Committee, the Working Group is made up of a mixture of both researchers and clinicians.

Member, Degree

Affiliation

Paul Haber AM,* MD FAChAM

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Drug Health Services, Royal Prince Alfred Hospital, Sydney Local Health District, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Benjamin Riordan, PhD

Centre for Alcohol Policy Research, School of Psychology and Public Health, La Trobe University, Victoria

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Daniel Winter, MPH

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Liz Barrett, MA

Drug Policy Modelling Program, Social Policy Research Centre, University of New South Wales, New South Wales

Alison Ritter, PhD

Drug Policy Modelling Program, Social Policy Research Centre, University of New South Wales, New South Wales

Kari Lancaster, PhD

Centre for Social Research in Health, Faculty of Arts and Science, University of New South Wales, New South Wales

Kate Seear, PhD

Law Research Services, Faculty of Law, Monash University, Victoria

John Saunders, MA, MB, MD

National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland

Jason Connor, PhD

National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland

School of Psychology, Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland

Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Brisbane, Queensland

Daniel Stjepanovic

National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland

Kerryn Butler, PhD

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Leanne Hides, PhD

Lives Lived Well Group, School of Psychology, National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland

Catherine Quinn, PhD

Lives Lived Well Group, School of Psychology, National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland

John Cunningham, PhD

Institute for Mental Health Policy Research, Center for Addiction and Mental Health, Toronto, Canada

Department of Psychology and Department of Psychiatry, University of Toronto, Canada

College of Health & Medicine, Australian National University, Australian Capital Territory

Frances Kay-Lambkin, PhD

School of Medicine and Public Health, The University of Newcastle, New South Wales

Nicholas Lintzeris, BMedSci, MBBS, PhD, FAChAM

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Drug and Alcohol Services, South Eastern Sydney Local Health District, New South Wales

Mathew Gullo, PhD (Clin Psych)

National Centre for Youth Substance Use Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Queensland

Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Brisbane, Queensland

Kirsten Morley, PhD

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Susan Rombouts, MD

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Nazila Jamshidi, MBBS B.Pharm (Hons) PhD, FaChAM

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Drug Health Services, Royal Prince Alfred Hospital, Sydney Local Health District, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Victoria Manning, PhD

Turning Point, Eastern Health, Melbourne, Victoria

Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria

Michael Savic, PhD

School of Psychological Sciences, Faculty of Medicine, Nursing and Health Sciences Monash University, Victoria

Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria

Dan Lubman*, MB ChB, PhD

Turning Point, Eastern Health, Melbourne, Victoria

Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria

Yvonne Bonomo, MBBS, PhD, FAChAM

Department of Addiction Medicine, St Vincent’s Hospital Melbourne, Victoria

Department of Medicine, University of Melbourne, Victoria

Amanda Norman, BA

Department of Addiction Medicine, St Vincent’s Hospital Melbourne, Victoria

Adam Pastor, BA MBBS, FAChAM

Department of Addiction Medicine, St Vincent’s Hospital Melbourne, Victoria

Department of Medicine, University of Melbourne, Victoria

Carolyn Day, PhD

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Natalie White, BappSc(OT), MPH

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Sharon Reid, PhD, MBBS, MPH, DRANZCOG, DipPaed

Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, New South Wales

Drug Health Services, Royal Prince Alfred Hospital, Sydney Local Health District, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Lucinda Burns, PhD, Grad Dip Health Policy, Prof Cert Pop Health Data, MPH, BA(Hons)

National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, New South Wales

Delyse Hutchinson, PhD/MClinPsych, BA/BSc (Hons)

Centre for Social and Early Emotional Development, School of Psychology, Faculty of Health, Deakin University, Victoria

National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, New South Wales

Centre for Adolescent Health, Murdoch Children’s Research Institute, Royal Children’s Hospital Melbourne, Victoria

Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria

Robert Assan

Robert Assan of Townsville, Queensland

Catherine Zheng, BSc

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Scott Wilson, MIndigH

Aboriginal Drug and Alcohol Council SA, South Australia

Centre of Research Excellence in Indigenous Health and Alcohol

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Bradley Freeburn

Bradley Freeburn of Blue Haven, New South Wales

John Boffa, MPH

Central Australian Aboriginal Congress, Alice Springs, Northern Territory

Gemma Purcell-Khodr, BA

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Michael Doyle, PhD

Centre of Research Excellence in Indigenous Health and Alcohol

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Kate Conigrave, FAChAM, FAFPHM, PhD

Centre of Research Excellence in Indigenous Health and Alcohol

Drug Health Services, Royal Prince Alfred Hospital, Sydney Local Health District, New South Wales

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Kenneth Curry, MB BS (Hons), MMedEd, FAChAM

Drug and Alcohol Services, Murrumbidgee Local Health District, New South Wales

Yasmine Iese, MHSc

Drug and Alcohol Multicultural Education Centre (DAMEC), New South Wales

Alison Laura Jaworski, BSc (Hons)

Drug and Alcohol Multicultural Education Centre (DAMEC), New South Wales

Julie Mooney-Somers, PhD

Sydney Health Ethics, Faculty of Medicine and Health, The University of Sydney, New South Wales

Nicola Black, PhD

National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, New South Wales

Technology Addiction Team, Brain and Mind Centre, University of Sydney, New South Wales

Sonja Memedovic, PhD

National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, New South Wales

Toby Lea, PhD

Centre for Social Research in Health, Faculty of Arts and Science, University of New South Wales, New South Wales

Amanda Roxburgh, PhD

National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Apo Demirkol, MD, MSc, MMed (Pain Mgt), PhD, FAFPHM, FAChAM, AFRACMA

Drug and Alcohol Services, South Eastern Sydney Local Health District, New South Wales

School of Population Health, Faculty of Medicine, University of New South Wales, New South Wales

Brian Draper, MBBS MD FRANZCP

Eastern Suburbs Older Persons' Mental Health Service, Randwick, South Eastern Sydney Local Health District, New South Wales

School of Psychiatry, Faculty of Medicine, University of New South Wales, New South Wales

Lauren Monds, PhD

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Nicole Ridley, DPsych

Drug and Alcohol Services, South Eastern Sydney Local Health District, New South Wales

Warren Logge, PhD

Drug Health Services, Royal Prince Alfred Hospital, Sydney Local Health District, New South Wales

Specialty of Addiction Medicine, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

Adrienne Withall, PhD

School of Population Health, Faculty of Medicine, University of New South Wales, New South Wales

Mike McDonough, FAChAM

Drug & Alcohol Services South Australia, SA Health, South Australia

Linda Gowing, PhD

Drug & Alcohol Services South Australia, SA Health, South Australia

Andrew J Baillie, MPsychol PhD MAPS FCCLP

Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, New South Wales

Allied Health, Sydney Local Health District, New South Wales

Edith Collins Centre (Translational Research in Alcohol Drugs and Toxicology), Sydney Local Health District, New South Wales

James Pham

Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, New South Wales

Lexine Stapinski, MClinPsych PhD

The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, New South Wales

Katherine Mills, PhD

The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, New South Wales

Christina Marel, PhD

The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, New South Wales

Maree Teesson AC, PhD

The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, New South Wales

Paul Clark, MBBS (Hons I) MPHTM PhD FRACP FAChAM

Department of Gastroenterology and Hepatology, Princess Alexandra and Mater Hospitals, Queensland

Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Brisbane, Queensland

Greenslopes Clinical Unit, Faculty of Medicine, The University of Queensland, Queensland

UQ-Mater Research Institute, Berghofer Queensland Medical Research Institute

Belaynew Wasie Taye, MD

Mater Research Institute, Faculty of Medicine, The University of Queensland, Queensland

Working Group Conflicts of Interest

Member Conflict How conflict is managed
Paul Haber AM Funded by the Lambert Cannabis Initiative at the University of Sydney to undertake clinical trials of cannabinoid treatment for alcohol withdrawal syndrome. Has served on industry advisory boards for Indivior, AbbVie and Gilead and has been an investigator on clinical trials supported by Camurus. He has also served on an International Advisory Board for Lundbeck in relation to Nalmefene (2013-2015) and Australia (2014). Cannabis is not discussed in these Guidelines and Indivior, AbbVie and Gilead do not market products for treatment of alcohol problems. Nalmefene is discussed in the pharmacotherapies chapter and while the drug is TGA approved, it is not available in Australia. To manage this conflict, Paul did not review the section on Nalmefene.
Dan Lubman Has received grant income form the ARC, NHMRC, Movember, beyondblue, VicHealth, Google, VGRF, NSW Health, the Victorian Department of Health and the Commonwealth Department of Health. Has also provided consultancy advice to Lundbeck and Indivior and has received travel support and speaker honoraria from Astra Zeneca, Janssen, Lundbeck, Shire, and Servier, though none of these organisations stand to benefit from the current project. DL has been an investigator on an untied education grant from Sequirus, unrelated to the current work.  To manage any potential conflicts, Dan did not review the pharmacotherapy section or other sections related to these conflicts.